XSNX (Novaccess Global) Total Liabilities: $10.09 Mil (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSNX Novaccess Global Inc XSNX
12 GF Score
Price $0.00
View Full Analysis

What is Novaccess Global Total Liabilities?

Novaccess Global XSNX 12 Total Liabilities is $10.09 Mil as of Sep. 2024. GuruFocus rates XSNX with a GF Score™ of 12/100.

Novaccess Global's Total Liabilities for the quarter that ended in Sep. 2024 was $10.09 Mil.

Novaccess Global's quarterly Total Liabilities increased from Mar. 2024 ($6.94 Mil) to Jun. 2024 ($7.70 Mil) and increased from Jun. 2024 ($7.70 Mil) to Sep. 2024 ($10.09 Mil).

Novaccess Global's annual Total Liabilities increased from Sep. 2022 ($4.78 Mil) to Sep. 2023 ($7.86 Mil) and increased from Sep. 2023 ($7.86 Mil) to Sep. 2024 ($10.09 Mil).


Novaccess Global Total Liabilities Historical Data

* Premium members only.

The historical data trend for Novaccess Global's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novaccess Global Total Liabilities Chart

Novaccess Global Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.57 4.14 4.78 7.86 10.09

Novaccess Global Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.86 6.45 6.94 7.70 10.09
XSNX
12GF Score
Novaccess Global Inc XSNX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novaccess Global Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Novaccess Global's Total Liabilities for the fiscal year that ended in Sep. 2024 is calculated as

Total Liabilities=Total Assets (A: Sep. 2024 )-Total Equity (A: Sep. 2024 )
=0.062--10.024
=10.09

Novaccess Global's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities=Total Assets (Q: Sep. 2024 )-Total Equity (Q: Sep. 2024 )
=0.062--10.024
=10.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $10.09 Mil mean?
Novaccess Global (XSNX) has a Total Liabilities of $10.09 Mil as of Sep. 2024. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Novaccess Global and its competitors.
Is Novaccess Global's Total Liabilities too high?
Novaccess Global's current Total Liabilities is $10.09 Mil. Overall, Novaccess Global has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novaccess Global's Total Liabilities compare to NBIO and BTAX?
Novaccess Global's Total Liabilities of $10.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Novaccess Global and its competitors. Novaccess Global's current Total Liabilities is $10.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novaccess Global stock overvalued right now?
Novaccess Global (XSNX) has a current Total Liabilities of $10.09 Mil. The current Total Liabilities is $10.09 Mil. Novaccess Global's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Novaccess Global (XSNX), the current Total Liabilities is $10.09 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novaccess Global Business Description

Address 459 Columbus Avenue, No. 607, New York, NY, USA, 10024
Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.
12GF Score

Get the complete analysis for XSNX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price